Search

everythinglearnresearchcommunity

for

Search:↓

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Conditions affecting sex development show that sexual diversity is a natural part of human variation.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Oxidative stress plays a role in female pattern baldness, causing an imbalance between harmful and protective elements in the body.

Smoking and alcohol worsen hair transplant results.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

American men are older, more obese, and have longer infertility than Canadian men.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Solanum nigrum extract may help regrow hair.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Finasteride does not prevent bladder cancer.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Various hair restoration methods can effectively promote hair growth.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Testosterone therapy increases bone density in older men with low testosterone levels.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.